
Rare Disease HCP Scientific Brief Generator
Generate evidence-based scientific briefs for rare disease HCP communications
What You Can Do
You can rapidly convert fragmented clinical evidence, trial data, and published literature into structured, scientifically rigorous briefings tailored for healthcare professional engagement. This skill organizes disease pathophysiology, epidemiology, diagnostic criteria, and competitive treatment landscapes into professionally formatted documents that meet regulatory and compliance standards, reducing the 8–16 hour manual synthesis process to minutes while maintaining clinical accuracy.
Features
Organize scattered trial data, publications, and abstracts into coherent clinical narratives organized by disease aspect or clinical question
Automatically identify and structure key efficacy, safety, and tolerability data from trial publications with citations
Generate accessible yet scientifically rigorous content balanced for healthcare professional comprehension
Identify potential medical/legal risk areas in draft content before submission to review teams
Create reusable briefing frameworks for recurring scenarios (diagnosis algorithms, pathophysiology deep-dives, treatment landscape comparisons)
Build anticipated HCP scientific questions with evidence-supported answers organized by therapeutic topic
Synthesize comparative treatment options and landscape analysis for rare disease indications
Example Output
Example 1: Disease Pathophysiology Brief
- Background on genetic mechanisms in rare lysosomal storage disorder
- Epidemiology summary (incidence, prevalence, age of onset)
- Clinical presentation and diagnostic algorithm with key biomarkers
- Current standard-of-care treatment options with efficacy data
- Flagged compliance note: "Consider medical review for comparative efficacy claims against competitor agents"
Example 2: Adverse Event Management Q&A
- Q: How is hepatotoxicity managed in rare disease populations?
- A: Evidence-based monitoring protocols with cited trial data and clinical guidance
- Risk stratification framework for dose modification
- HCP talking points with reference citations
Example 3: Speaker Training Briefing
- Key epidemiological facts and unmet needs summary
- Trial design overview and primary/secondary endpoints
- Safety profile across patient subpopulations with adverse event frequency tables
- Anticipated HCP questions with clinical context
What's Included
- SKILL.md: Complete instruction file with prompting frameworks for rare disease brief generation
- Briefing template: Standardized structure for disease state, epidemiology, diagnostics, treatment landscape, and safety sections
- Evidence extraction checklist: Systematic approach for identifying and organizing trial data, publications, and clinical evidence
- Compliance risk matrix: Guidance on flagging medical/legal review areas (comparative claims, labeled/off-label discussions, unsubstantiated claims)
- Q&A development framework: Structured format for HCP question-answer pairs organized by therapeutic topic
Who It's For
- Medical Science Liaisons (MSLs) — Managing rare disease portfolios and preparing HCP-facing scientific communications
- Rare disease commercial teams — Building disease state education materials and competitive briefings
- Medical Affairs professionals — Synthesizing clinical evidence for speaker training and advisory board preparation
- Clinical educators — Creating accessible scientific content for HCP engagement in specialty indications
- Regulatory/medical compliance reviewers — Preparing draft content for streamlined review cycles
Best For
- Scientific briefing preparation for HCP meetings, advisory boards, and speaker training programs
- Disease state education for newly launched rare disease indications or territory expansion
- Evidence synthesis converting trial publications and abstracts into narrative summaries
- Competitive landscape analysis comparing treatment options and positioning across rare disease indications
- Q&A and anticipated objection documents for HCP scientific discussions organized by therapeutic topic







